ECP was developed as a treatment for advanced cutaneous T Cell lymphoma of the Mycosis Fungoides or Sezary Syndrome types. Treatment and the needed equipment is not widely available and is expensive. So it’s not scaleable for widespread use against Covid. For those who have access to the needed equipment and wish to try it, fine.